Esperion Therapeutics, Inc. Made Headway

Tue, Nov 23, 2021 at 05:30 PM
Esperion Therapeutics, Inc. Made Headway

Esperion Therapeutics, Inc. (ESPR:NASDAQ) jumped higher at $10.02, representing a gain of 40.7%. On Mon, Nov 22, 2021, ESPR:NASDAQ touched a New 2-Week Low of $7.12. The stock got featured on our News Catalysts scanner on Fri, Nov 12, 2021 at 07:42 AM in the 'MISCELLANEOUS' category. From Mon, Nov 08, 2021, the stock recorded 0.00% Up Days and 0.00% Green Days

The stock spiked on Wed, Nov 03, 2021 at $10.83 with a volume of 1M+.

About Esperion Therapeutics, Inc. (ESPR:NASDAQ)

Esperion Therapeutics Inc is a pharmaceutical company focused on developing and commercializing oral, low-density lipoprotein cholesterol, or LDL-C, lowering therapies for the treatment of patients with elevated LDL-C.

Share
Get 50% Off Premium Subscription
$19.99 USD
Limited-Time Discount
Your price will remain at $9.99 USD after the discount period
$9.99 USD
monthly
Signup 7 Days Trial. No Credit Card Required!
Ever wanted to explore stocks that have recently spiked... stocks moving sideways... or other trends? You're in the right place! Check StockTreats features.